Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy.
暂无分享,去创建一个
Matthias Guckenberger | Kurt Baier | Thomas Krieger | Michael Flentje | Anne Richter | T. Krieger | M. Flentje | M. Guckenberger | J. Wilbert | K. Baier | G. Mueller | Anne Richter | B. Polat | Buelent Polat | Juergen Wilbert | Gerd Mueller | A. Richter
[1] G. Glatting,et al. Choosing the optimal fit function: comparison of the Akaike information criterion and the F-test. , 2007, Medical physics.
[2] Joos V Lebesque,et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. , 2003, International journal of radiation oncology, biology, physics.
[3] C. Ling,et al. Results of a phase I dose‐escalation study using three‐dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma , 2005, Cancer.
[4] K. Forster,et al. The relationship between local dose and loss of function for irradiated lung. , 2003, International journal of radiation oncology, biology, physics.
[5] Joe Y. Chang,et al. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.
[6] R K Ten Haken,et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. , 1998, International journal of radiation oncology, biology, physics.
[7] K. Ohtomo,et al. Exceptionally high incidence of symptomatic grade 2–5 radiation pneumonitis after stereotactic radiation therapy for lung tumors , 2007, Radiation oncology.
[8] Matthias Guckenberger,et al. Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[9] J A Purdy,et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) , 1999, International journal of radiation oncology, biology, physics.
[10] Zhongxing Liao,et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). , 2005, International journal of radiation oncology, biology, physics.
[11] W. Schlegel,et al. Prediction of radiation-induced changes in the lung after stereotactic body radiation therapy of non-small-cell lung cancer. , 2007, International journal of radiation oncology, biology, physics.
[12] Matthias Guckenberger,et al. Cone-beam CT based image-guidance for extracranial stereotactic radiotherapy of intrapulmonary tumors , 2006, Acta oncologica.
[13] Matthias Guckenberger,et al. Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation. , 2009, International journal of radiation oncology, biology, physics.
[14] J. Lebesque,et al. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. , 2006, International journal of radiation oncology, biology, physics.
[15] J. Lebesque,et al. The simultaneous boost technique: the concept of relative normalized total dose. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[16] A. Agresti,et al. Approximate is Better than “Exact” for Interval Estimation of Binomial Proportions , 1998 .
[17] E. Smit,et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.
[18] Y. Onodera,et al. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy. , 2008, International journal of radiation oncology, biology, physics.
[19] X Allen Li,et al. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy. , 2004, Physics in medicine and biology.
[20] S. Moolgavkar,et al. A Method for Computing Profile-Likelihood- Based Confidence Intervals , 1988 .
[21] M. Flentje,et al. A Little to a Lot or a Lot to a Little? , 2003, Strahlentherapie und Onkologie.
[22] Jan-Jakob Sonke,et al. Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[23] Lawrence B Marks,et al. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. , 2008, Seminars in radiation oncology.
[24] J. Bedford,et al. Review of hypofractionated small volume radiotherapy for early-stage non-small cell lung cancer. , 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).
[25] Hiroki Shirato,et al. STEREOTACTIC RADIATION THERAPY WORKSHOP Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study , 2007 .
[26] David Pérol,et al. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[27] Matthias Guckenberger,et al. Intra-fractional uncertainties in cone-beam CT based image-guided radiotherapy (IGRT) of pulmonary tumors. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[28] E. Smit,et al. Stereotactic radiotherapy for centrally located early-stage lung tumors. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] Andrew Jackson,et al. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. , 2004, International journal of radiation oncology, biology, physics.
[30] Seong Soo Shin,et al. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus. , 2009, Lung cancer.
[31] T. Kimura,et al. CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: are patients with pulmonary emphysema also candidates for SBRT for lung cancers? , 2006, International journal of radiation oncology, biology, physics.
[32] S. Kuribayashi,et al. Radiation injury after hypofractionated stereotactic radiotherapy for peripheral small lung tumors: serial changes on CT. , 2004, AJR. American journal of roentgenology.
[33] Lech Papiez,et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] José Belderbos,et al. Biology contributionComparing different NTCP models that predict the incidence of radiation pneumonitis , 2003 .
[35] M. Goitein,et al. Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.
[36] Jeffrey Bradley,et al. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. , 2005, International journal of radiation oncology, biology, physics.
[37] M. Hiraoka,et al. Evaluation of lung injury after three-dimensional conformal stereotactic radiation therapy for solitary lung tumors: CT appearance. , 2004, Radiology.